West Pharmaceutical raises full-year outlook
West Pharmaceutical raised its full-year outlook. Its shares rose in morning trading.
Related stories
VAMOS Q3 EBITDA at 1 billion reais, matching IBES estimate
VAMOS reported Q3 EBITDA of 1 billion reais versus an IBES estimate of 1 billion reais.
M impact | EARNINGS | Oct 29, 2026, 11:18 PM UTC
Vamos posts R$1 billion EBITDA in third quarter
Vamos reported EBITDA of R$1 billion for the third quarter, matching the IBES estimate of R$1 billion.
M impact | EARNINGS | Oct 29, 2026, 11:18 PM UTC
Vamos reports R$151 million net profit in third quarter
Vamos reported third-quarter net profit of R$151 million; the IBES estimate was R$134 million.
M impact | EARNINGS | Oct 29, 2026, 11:18 PM UTC
NetLink NBN Trust 1H revenue S$202.6M vs. S$207.1M
L impact | EARNINGS | Oct 29, 2026, 11:13 PM UTC
Kiwoom Securities Q3 Net Income Falls 26% Year-on-Year
M impact | EARNINGS | Oct 29, 2026, 11:12 PM UTC
Pinnacle Bank Q3 Net Income Falls 78% to $235,000
M impact | EARNINGS | Oct 29, 2026, 11:11 PM UTC